The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
New Antithrombotic Drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
Bhatt, D. L., Fox, K. A. A., Hacke, W., Berger, P. B., Black, H. R., Boden, W. E., Cacoub, P., Cohen, E. A., Creager, M. A., Easton, J. D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060989 · Cited by 2,837
Diener, H.-C., Bogousslavsky, J., Brass, L. M., Cimminiello, C., Csiba, L., Kaste, M., Leys, D., Matias-Guiu, J., & Rupprecht, H.-J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16721-4 · Cited by 2,275
Sabatine, M. S., Cannon, C. P., Gibson, C. M., López-Sendón, J. L., Montalescot, G., Theroux, P., Claeys, M. J., Cools, F., Hill, K. A., Skene, A. M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050522 · Cited by 1,924
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67660-x · Cited by 1,858
Hemostasis and Thrombosis: Basic Principles and Clinical Practice.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-504_7 · Cited by 1,854
Gurbel, P. A., Bliden, K. P., Hiatt, B. L., & O’Connor, C. M. (2003) · Circulation · doi:10.1161/01.cir.0000072771.11429.83 · Cited by 1,544
Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa055443 · Cited by 1,228
Gurbel, P. A., Bliden, K. P., Butler, K., Tantry, U. S., Gesheff, T., Wei, C., Teng, R., Antonino, M. J., Patil, S. B., Karunakaran, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.912550 · Cited by 1,159
Eriksson, B. I., Dahl, O. E., Rosencher, N., Kurth, A. A., van Dijk, C. N., Frostick, S. P., Prins, M. H., Hettiarachchi, R., Hantel, S., Schnee, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61445-7 · Cited by 1,116
Eikelboom, J. W., Hirsh, J., Weitz, J. I., Johnston, M., Yi, Q., & Yusuf, S. (2002) · Circulation · doi:10.1161/01.cir.0000013777.21160.07 · Cited by 1,053
Self-citationHacke, W., Albers, G., Al-Rawi, Y., Bogousslavsky, J., Davalos, A., Eliasziw, M., Fischer, M., Furlan, A., Kaste, M., Lees, K. R., et al. (2005) · Stroke · doi:10.1161/01.str.0000149938.08731.2c · Cited by 1,015
ERIKSSON, B. I., DAHL, O. E., ROSENCHER, N., KURTH, A. A., VAN DIJK, C. N., FROSTICK, S. P., KÄLEBO, P., CHRISTIANSEN, A. V., HANTEL, S., HETTIARACHCHI, R., et al. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02748.x · Cited by 979
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
Sacco, R. L., Diener, H.-C., Yusuf, S., Cotton, D., Ôunpuu, S., Lawton, W. A., Palesch, Y., Martin, R. H., Albers, G. W., Bath, P., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805002 · Cited by 961
Abraham, E., Reinhart, K., Opal, S., Demeyer, I., Doig, C., Rodriguez, A. L., Beale, R., Svoboda, P., Laterre, P. F., Simon, S., et al. (2003) · JAMA · doi:10.1001/jama.290.2.238 · Cited by 959
The OASIS-6 Trial Group* (2006) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.295.13.joc60038 · Cited by 906
Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death
Abraham, E., Laterre, P.-F., Garg, R., Levy, H., Talwar, D., Trzaskoma, B. L., François, B., Guy, J. S., Brückmann, M., Rea-Neto, Á., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050935 · Cited by 890
Stangier, J., Rathgen, K., Stähle, H., Gansser, D., & Roth, W. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02899.x · Cited by 887
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa035451 · Cited by 887
Cohen, A. T., Davidson, B. L., Gallus, A. S., Lassen, M. R., Prins, M. H., Tomkowski, W., Turpie, A. G. G., Egberts, J. F. M., & Lensing, A. W. A. (2006) · BMJ · doi:10.1136/bmj.38733.466748.7c · Cited by 857
Fox, K. A. A., Mehta, S. R., Peters, R., Zhao, F., Lakkis, N., Gersh, B. J., & Yusuf, S. (2004) · Circulation · doi:10.1161/01.cir.0000140675.85342.1b · Cited by 835
Husted, S., Emanuelsson, H., Heptinstall, S., Sandset, P. M., Wickens, M., & Peters, G. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi754 · Cited by 743
Turpie, A. G. G. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.16.1833 · Cited by 736
BRANDT, J. T., CLOSE, S. L., ITURRIA, S. J., PAYNE, C. D., FARID, N. A., ERNEST, C. S., LACHNO, D. R., SALAZAR, D., & WINTERS, K. J. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02775.x · Cited by 734
Peters, R. J. G., Mehta, S. R., Fox, K. A. A., Zhao, F., Lewis, B. S., Kopecky, S. L., Diaz, R., Commerford, P. J., Valentin, V., & Yusuf, S. (2003) · Circulation · doi:10.1161/01.cir.0000091201.39590.cb · Cited by 706
Apixaban or Enoxaparin for Thromboprophylaxis after Knee Replacement
Lassen, M. R., Raskob, G. E., Gallus, A., Pineo, G., Chen, D., & Portman, R. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810773 · Cited by 695
Intravenous Platelet Blockade with Cangrelor during PCI
Bhatt, D. L., Lincoff, A. M., Gibson, C. M., Stone, G. W., McNulty, S., Montalescot, G., Kleiman, N. S., Goodman, S. G., White, H. D., Mahaffey, K. W., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908629 · Cited by 648
Kubitza, D., Becka, M., Wensing, G., Voith, B., & Zuehlsdorf, M. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0043-5 · Cited by 640
Platelet Inhibition with Cangrelor in Patients Undergoing PCI
Harrington, R. A., Stone, G. W., McNulty, S., White, H. D., Lincoff, A. M., Gibson, C. M., Pollack, C. V., Montalescot, G., Mahaffey, K. W., Kleiman, N. S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908628 · Cited by 625
von Beckerath, N., Taubert, D., Pogatsa-Murray, G., Schömig, E., Kastrati, A., & Schömig, A. (2005) · Circulation · doi:10.1161/circulationaha.105.559088 · Cited by 623
Büller, H. R., Davidson, B. L., Decousus, H., Gallus, A., Gent, M., Piovella, F., Prins, M. H., Raskob, G., Segers, A. E. M., Cariou, R., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-11-200406010-00007 · Cited by 617
Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans
Raghavan, N., Frost, C. E., Yu, Z., He, K., Zhang, H., Humphreys, W. G., Pinto, D., Chen, S., Bonacorsi, S., Wong, P. C., et al. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.023143 · Cited by 612
Hacke, W., Furlan, A. J., Al-Rawi, Y., Davalos, A., Fiebach, J. B., Gruber, F., Kaste, M., Lipka, L. J., Pedraza, S., Ringleb, P. A., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70267-9 · Cited by 574
Furlan, A. J., Eyding, D., Albers, G. W., Al-Rawi, Y., Lees, K. R., Rowley, H. A., Sachara, C., Soehngen, M., Warach, S., & Hacke, W. (2006) · Stroke · doi:10.1161/01.str.0000217403.66996.6d · Cited by 540
Eriksson, B. I., Quinlan, D. J., & Weitz, J. I. (2009) · Clinical Pharmacokinetics · doi:10.2165/0003088-200948010-00001 · Cited by 522
Self-citationRNA aptamers as reversible antagonists of coagulation factor IXa
Rusconi, C. P., Scardino, E., Layzer, J., Pitoc, G. A., Ortel, T. L., Monroe, D., & Sullenger, B. A. (2002) · Nature · doi:10.1038/nature00963 · Cited by 512
Hankey, G. J., & Eikelboom, J. W. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68040-9 · Cited by 505
Nadel, S., Goldstein, B., Williams, M. D., Dalton, H., Peters, M., Macias, W. L., Abd-Allah, S. A., Levy, H., Angle, R., Wang, D., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60411-5 · Cited by 501
Cannon, C. P., Husted, S., Harrington, R. A., Scirica, B. M., Emanuelsson, H., Peters, G., & Storey, R. F. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.053 · Cited by 497
Lau, W. C., Gurbel, P. A., Watkins, P. B., Neer, C. J., Hopp, A. S., Carville, D. G. M., Guyer, K. E., Tait, A. R., & Bates, E. R. (2004) · Circulation · doi:10.1161/01.cir.0000112378.09325.f9 · Cited by 487
APPRAISE Steering Committee and Investigators (2009) · Circulation · doi:10.1161/circulationaha.108.832139 · Cited by 461
Wiviott, S. D., Antman, E. M., Winters, K. J., Weerakkody, G., Murphy, S. A., Behounek, B. D., Carney, R. J., Lazzam, C., McKay, R. G., McCabe, C. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.502815 · Cited by 381
LASSEN, M. R., DAVIDSON, B. L., GALLUS, A., PINEO, G., ANSELL, J., & DEITCHMAN, D. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02764.x · Cited by 374
Berger, J. S., Krantz, M. J., Kittelson, J. M., & Hiatt, W. R. (2009) · JAMA · doi:10.1001/jama.2009.623 · Cited by 360
Agnelli, G., Gallus, A., Goldhaber, S. Z., Haas, S., Huisman, M. V., Hull, R. D., Kakkar, A. K., Misselwitz, F., & Schellong, S. (2007) · Circulation · doi:10.1161/circulationaha.106.668020 · Cited by 337
Agnelli, G., Bergqvist, D., Cohen, A. T., Gallus, A. S., & Gent, M. (2005) · British Journal of Surgery · doi:10.1002/bjs.5154 · Cited by 337
Eriksson, B. I., Borris, L. C., Dahl, O. E., Haas, S., Huisman, M. V., Kakkar, A. K., Muehlhofer, E., Dierig, C., Misselwitz, F., & Kälebo, P. (2006) · Circulation · doi:10.1161/circulationaha.106.642074 · Cited by 335
Idraparinux versus Standard Therapy for Venous Thromboembolic Disease
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa064247 · Cited by 335
Savi, P., & Herbert, J.-M. (2005) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2005-869523 · Cited by 327
TURPIE, A. G. G., FISHER, W. D., BAUER, K. A., KWONG, L. M., IRWIN, M. W., KÄLEBO, P., MISSELWITZ, F., & GENT, M. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01602.x · Cited by 302
ERIKSSON, B. I., BORRIS, L., DAHL, O. E., HAAS, S., HUISMAN, M. V., KAKKAR, A. K., MISSELWITZ, F., & KÄLEBO, P. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01657.x · Cited by 302
Becker, R. C., Moliterno, D. J., Jennings, L. K., Pieper, K. S., Pei, J., Niederman, A., Ziada, K. M., Berman, G., Strony, J., Joseph, D., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60230-0 · Cited by 299
Chackalamannil, S., Wang, Y., Greenlee, W. J., Hu, Z., Xia, Y., Ahn, H.-S., Boykow, G., Hsieh, Y., Palamanda, J., Agans-Fantuzzi, J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800180e · Cited by 269
Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review
Hovens, M. M. C., Snoep, J. D., Eikenboom, J. C. J., van der Bom, J. G., Mertens, B. J. A., & Huisman, M. V. (2007) · American Heart Journal · doi:10.1016/j.ahj.2006.10.040 · Cited by 269
Hemostasis and Thrombosis: Basic Principles and Clinical Practice
Holcomb, G. R. (1988) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)64968-4 · Cited by 267
Abraham, E., Reinhart, K., Svoboda, P., Seibert, A., Olthoff, D., Dal Nogare, A., Postier, R., Hempelmann, G., Butler, T., Martin, E., et al. (2001) · Critical Care Medicine · doi:10.1097/00003246-200111000-00007 · Cited by 253
Preclinical and Clinical Studies with Selective Reversible Direct P2Y12Antagonists
van Giezen, J. J. J., & Humphries, R. G. (2005) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2005-869525 · Cited by 251
Eikelboom, J. W., Hankey, G. J., Thom, J., Bhatt, D. L., Steg, P. G., Montalescot, G., Johnston, S. C., Steinhubl, S. R., Mak, K.-H., Easton, J. D., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.768283 · Cited by 232
Turpie, A. G. G. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.139402 · Cited by 224
Dyke, C. K., Steinhubl, S. R., Kleiman, N. S., Cannon, R. O., Aberle, L. G., Lin, M., Myles, S. K., Melloni, C., Harrington, R. A., Alexander, J. H., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.668434 · Cited by 222
Greenbaum, A. B., Grines, C. L., Bittl, J. A., Becker, R. C., Kereiakes, D. J., Gilchrist, I. C., Clegg, J., Stankowski, J. E., Grogan, D. R., Harrington, R. A., et al. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.11.014 · Cited by 215
Novel Aspects of Blood Coagulation Factor XIII. I. Structure, Distribution, Activation, and Function
Muszbek, L., Adany, R., & Mikkola, H. (1996) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369609084691 · Cited by 201
Hepatic Findings in Long-Term Clinical Trials of Ximelagatran
Lee, W. M., Larrey, D., Olsson, R., Lewis, J. H., Keisu, M., Auclert, L., & Sheth, S. (2005) · Drug Safety · doi:10.2165/00002018-200528040-00006 · Cited by 189
Jang, Y., Guzman, L. A., Lincoff, A. M., Gottsauner-Wolf, M., Forudi, F., Hart, C. E., Courtman, D. W., Ezban, M., Ellis, S. G., & Topol, E. J. (1995) · Circulation · doi:10.1161/01.cir.92.10.3041 · Cited by 182
Tran, H. (2004) · JAMA · doi:10.1001/jama.292.15.1867 · Cited by 181
Kapetanakis, E. I., Medlam, D. A., Boyce, S. W., Haile, E., Hill, P. C., Dullum, M. K. C., Bafi, A. S., Petro, K. R., & Corso, P. J. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi074 · Cited by 179
Cappello, M., Vlasuk, G. P., Bergum, P. W., Huang, S., & Hotez, P. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.13.6152 · Cited by 173
Morrow, D. A., Scirica, B. M., Fox, K. A. A., Berman, G., Strony, J., Veltri, E., Bonaca, M. P., Fish, P., McCabe, C. H., & Braunwald, E. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.06.027 · Cited by 172
Bauer, K., Davidson, B., Fisher, W., Gent, M., Huo, M., Sinha, U., Gretler, D., Turpie, A., & for the EXPERT Study Group (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-07-0460 · Cited by 161
Eriksson, B. I., Borris, L. C., Dahl, O. E., Haas, S. K., Huisman, M. V., Kakkar, A. K., Misselwitz, F., Muehlhofer, E., & Kälebo, P. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2006.12.025 · Cited by 145
Belhassen, L., Pelle, G., Dubois‐Randé, J., & Adnot, S. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00048-2 · Cited by 143
NERISERNERI, G., COCCHERI, S., Marubini, E., & Violi, F. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.07.013 · Cited by 140
Sabatine, M. S., Antman, E. M., Widimský, P., Ebrahim, I. O., Kiss, R. G., Saaiman, A., Polášek, R., Contant, C. F., McCabe, C. H., & Braunwald, E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61454-9 · Cited by 139
G-Protein–Coupled Receptors as Signaling Targets for Antiplatelet Therapy
Smyth, S. S., Woulfe, D. S., Weitz, J. I., Gachet, C., Conley, P. B., Goodman, S. G., Roe, M. T., Kuliopulos, A., Moliterno, D. J., French, P. A., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.176388 · Cited by 138
Self-citationWeitz, J. I., & Crowther, M. A. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(02)00093-2 · Cited by 132
Self-citationChan, M. Y., Cohen, M. G., Dyke, C. K., Myles, S. K., Aberle, L. G., Lin, M. J., Walder, J. S., Steinhubl, S. R., Gilchrist, I. C., Kleiman, N. S., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.745687 · Cited by 130
Direct Thrombin Inhibitors in Acute Coronary Syndromes
Weitz, J. I., & Buller, H. R. (2002) · Circulation · doi:10.1161/hc0802.104331 · Cited by 130
Self-citationPersist investigators (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2003.00516.x · Cited by 128
Jakubowski, J. A., Matsushima, N., Asai, F., Naganuma, H., Brandt, J. T., Hirota, T., Freestone, S., & Winters, K. J. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02792.x · Cited by 128
Aspirin Plus Dipyridamole Versus Aspirin for Prevention of Vascular Events After Stroke or TIA
Verro, P., Gorelick, P. B., & Nguyen, D. V. (2008) · Stroke · doi:10.1161/strokeaha.107.496281 · Cited by 125
Extended Prophylaxis of Venous Thromboembolism with Idraparinux
The van Gogh Investigators (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067703 · Cited by 124
The roles of fibrinogen and fibrin in hemostasis and thrombosis.
Mw, M. (1992) · PubMed · Cited by 117
Siller-Matula, J. M., Krumphuber, J., & Jilma, B. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00555.x · Cited by 116
Parkinson, J. F., Grinnell, B. W., Moore, R. E. B., Hoskins, J., Vlahos, C. J., & Bang, N. U. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38386-3 · Cited by 113
Eriksson, B. I., Turpie, A. G. G., Lassen, M. R., Prins, M. H., Agnelli, G., Kälebo, P., GAILLARD, M. L., & Meems, L. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02644.x · Cited by 109
Bergum, P. W., Cruikshank, A. M., Maki, S. L., Kelly, C. R., Ruf, W., & Vlasuk, G. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009116200 · Cited by 109
Moons, A. H., Peters, R. J. G., Bijsterveld, N. R., Piek, J. J., Prins, M. H., Vlasuk, G. P., Rote, W. E., & Buller, H. R. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00478-9 · Cited by 104
Agnelli, G., Haas, S. K., Ginsberg, J. S., Krueger, K., Dmitrienko, A. A., & Brandt, J. T. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02436.x · Cited by 103
Berger, J. S., Roe, M. T., Gibson, C. M., Kilaru, R., Green, C. L., Melton, L. G., Blankenship, J., Metzger, D. C., Granger, C. B., Gretler, D. D., et al. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.10.010 · Cited by 100
Bolus Fibrinolytic Therapy in Acute Myocardial Infarction
Llevadot, J. (2001) · JAMA · doi:10.1001/jama.286.4.442 · Cited by 97
Lip, G. Y. H., Rasmussen, L. H., Olsson, S., Jensen, E. C., Persson, A., Eriksson, U. G., & Wåhlander, K. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp318 · Cited by 97
Apixaban, an oral direct factor Xa inhibitor, inhibits human clot-bound factor Xa activity in vitro
Jiang, X., Crain, E. J., Luettgen, J. M., Schumacher, W., & Wong, P. C. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-07-0486 · Cited by 94
Direct fibrinolytic agents: biochemical attributes, preclinical foundation and clinical potential
Marder, V. J., & Novokhatny, V. V. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03701.x · Cited by 93
BALSANO, F., & Violi, F. (1993) · Circulation · doi:10.1161/01.cir.87.5.1563 · Cited by 91
Setyono-Han, B., Stürzebecher, J., Schmalix, W. A., Muehlenweg, B., Sieuwerts, A. M., Timmermans, M. A. M., Magdolen, V., Schmitt, M., Klijn, J. G. M., & Foekens, J. A. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-11-0712 · Cited by 85
Nimjee, S. M., Keys, J. R., Pitoc, G. A., Quick, G., Rusconi, C. P., & Sullenger, B. A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.04.006 · Cited by 83
Oral direct thrombin inhibitors in clinical development
Gustafsson, D. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01225.x · Cited by 79
Giugliano, R. P., Wiviott, S. D., Stone, P. H., Simon, D. I., Schweiger, M. J., Bouchard, A., Leesar, M. A., Goulder, M. A., Deitcher, S. R., McCabe, C. H., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.065 · Cited by 76
Bousser, M., Amarenco, P., Chamorro, Á., Fisher, M., Ford, I., Fox, K. M., Hennerici, M. G., Mattle, H. P., Rothwell, P. M., & on behalf of the PERFORM Study Investigators (2009) · Cerebrovascular Diseases · doi:10.1159/000212671 · Cited by 70
Attenuation of the Synthesis of Plasminogen Activator Inhibitor Type 1 by Niacin
Brown, S. L., Sobel, B. E., & Fujii, S. (1995) · Circulation · doi:10.1161/01.cir.92.4.767 · Cited by 69
The specific thromboxane receptor antagonist S18886: pharmacokinetic and pharmacodynamic studies
Gaussem, P., Reny, J., Thalamas, C., CHATELAIN, N., KROUMOVA, M., JUDE, B., Boneu, B., & Fiessinger, J. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01468.x · Cited by 68
Lecompte, T. (2006) · Journal des Maladies Vasculaires · doi:10.1016/s0398-0499(06)76547-7 · Cited by 66
Aspirin Resistance: Definitions, Mechanisms, Prevalence, and Clinical Significance
Macchi, L., Sorel, N., & Christiaens, L. P. (2005) · Current Pharmaceutical Design · doi:10.2174/138161206775193064 · Cited by 65
Ertongur, S., Lang, S., Mack, B., Wosikowski, K., Muehlenweg, B., & Gires, O. (2004) · International Journal of Cancer · doi:10.1002/ijc.20192 · Cited by 61
Tantry, U. S., Bliden, K. P., & Gurbel, P. A. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.2.225 · Cited by 54
Inhibition of Factor IX(a) Is Protective in a Rat Model of Thromboembolic Stroke
Toomey, J. R., Valocik, R. E., Koster, P. F., Gabriel, M. A., McVey, M. J., Hart, T. K., Ohlstein, E. H., Parsons, A. A., & Barone, F. C. (2002) · Stroke · doi:10.1161/hs0202.102950 · Cited by 51
Gersh, B. J., & Antman, E. M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi775 · Cited by 51
Chow, F., Benincosa, L. J., Sheth, S. B., Wilson, D., Davis, C. B., Minthorn, E. A., & Jusko, W. J. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.122276 · Cited by 49
Jacquemin, M. G., Radcliffe, C. M., Lavend’homme, R., Wormald, M. R., VanderElst, L., Wallays, G., Dewaele, J., Collen, D., Vermylen, J., Dwek, R. A., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01900.x · Cited by 47
Laterre, P., Opal, S. M., Abraham, E. H., LaRosa, S. P., Creasey, A. A., Xie, F., Poole, L., & Wunderink, R. G. (2009) · Critical Care · doi:10.1186/cc7747 · Cited by 44
Taylor, F. B. (2009) · Haemostasis · doi:10.1159/000217246 · Cited by 40
Inhibition of Endothelial Cell Expression of Plasminogen Activator Inhibitor Type-1 by Gemfibrozil
Fujii, S., Sawa, H., & Sobel, B. E. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649642 · Cited by 39
Personalized medicine and antiplatelet therapy: ready for prime time?
Verstuyft, C., Simon, T., & Kim, R. B. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp295 · Cited by 38
Bousser, M., Amarenco, P., Chamorro, Á., Fisher, M., Ford, I., Fox, K., Hennerici, M. G., Mattle, H. P., & Rothwell, P. M. (2009) · Cerebrovascular Diseases · doi:10.1159/000216835 · Cited by 37
Toomey, J. R., Blackburn, M. N., Storer, B. L., Valocik, R. E., Koster, P. F., & Feuerstein, G. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(00)00299-1 · Cited by 35
Milani, M., Longoni, A., & Maderna, M. (1996) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1996.00503.x · Cited by 34
Dyspnoea after antiplatelet agents: the AZD6140 controversy
Serebruany, V. L., Stebbing, J., & Atar, D. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01294.x · Cited by 31
Clopidogrel Resistance: Implications for Coronary Stenting
Gurbel, P. A., Lau, W. C., Bliden, K. P., & Tantry, U. S. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776361345 · Cited by 22
Cited by
Antithrombotic Therapy for Venous Thromboembolic Disease
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., & Comerota, A. J. (2008) · Chest · doi:10.1378/chest.08-0658 · Cited by 1,996
Horlocker, T. T., Wedel, D. J., Rowlingson, J. C., Enneking, F. K., Kopp, S. L., Benzon, H. T., Brown, D. L., Heit, J. A., Mulroy, M. F., Rosenquist, R. W., et al. (2010) · Regional Anesthesia and Pain Medicine · doi:10.1097/aap.0b013e3181c15c70 · Cited by 1,501
Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology
Kozek-Langenecker, S. A., Afshari, A., Albaladejo, P., Santullano, C. A. A., De Robertis, E., Filipescu, D. C., Fries, D., Görlinger, K., Haas, T., Imberger, G., et al. (2013) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32835f4d5b · Cited by 909
Ruiz-Irastorza, G., Crowther, M., Branch, W., & Khamashta, M. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60709-x · Cited by 831
Gogarten, W., Vandermeulen, E., Van Aken, H., Kozek, S., Llau, J. V., & Samama, C. M. (2010) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32833f6f6f · Cited by 529
Metadata
- Authors
- Weitz, J. I., Hirsh, J., & Samama, M. M.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2008-06
- Volume
- 133
- Issue
- 6
- Pages
- 234S-256S
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2145834923
- Cited by
- 262
- References
- 125
- FWCI
- 26.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.